38 262

Cited 0 times in

병적 근시와 동반된 맥락막 신생혈관에서 광역학 치료의 임상 적용

Other Titles
 Photodynamic Therapy in Practice: A Review of Experiences with Myopic CNV in Korean Patients 
 정은지  ;  오현섭  ;  고형준  ;  이성철  ;  권오웅 
 Journal of the Korean Ophthalmological Society (대한안과학회지), Vol.46(4) : 664-670, 2005 
Journal Title
 Journal of the Korean Ophthalmological Society (대한안과학회지) 
Issue Date
Purpose: To evaluate the effects of photodynamic therapy with verteporfin on visual acuity and fluorescein angiography in choroidal neovascularization (CNV) associated with pathologic myopia and to determine if this treatment could reproduce the results achieved in the Verteporfin in Photodynamic Therapy (VIP) Trial in Korean patients. Methods: Forty-two eyes of 39 patients with CNV secondary to pathologic myopia were included. A retrospective review of their clinical records and fluorescein angiography was done. The patients underwent photodynamic therapy with verteporfin and were followed up for more than 6 months after the therapy. The change in best corrected visual acuity (BCVA) and leakage in fluorescein angiography were evaluated. Results: The mean age of the patients was 39.6 and mean follow-up period was 23.5 months. The BCVA of the patients improved in 22 (52.4%) eyes, was unchanged in 13 (30.9%), and worsened in 7 (16.7%). The leakage in fluorescein angiography decreased in 25 (59.5%) eyes. Conclusions: Photodynamic therapy with verteporfin for myopic CNV in Korean patients appeared to be effective in stabilization of the lesions and improvement of visual acuity.
Files in This Item:
T200500350.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers
Yonsei Authors
고형준(Koh, Hyoung Jun) ORCID logo https://orcid.org/0000-0002-5932-8516
권오웅(Kwon, Oh Woong)
오현섭(Oh, Hyun Sub)
이성철(Lee, Sung Chul) ORCID logo https://orcid.org/0000-0001-9438-2385
RIS (EndNote)
XLS (Excel)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.